Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |